Silence Therapeutics plc Buy: siRNA progress in PV & ASCVD, divesiran SANRECO data and Aug 2026 catalyst; watch cash ...

In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

While Eli Lilly continues to ride an historic stretch of company growth and performance in the annals of Big Pharma, the now ...

Researchers have uncovered a previously underappreciated mechanism involved in Alzheimer’s disease and developed a compound ...

Symeres has already seen strong interest from clients seeking enabling formulation solutions for poorly soluble compounds.

Neglected tropical diseases (NTDs) remain a significant global health challenge, disproportionately affecting vulnerable populations in low- and ...

Illinois, is backing legislation he says would lower prescription drug costs by targeting the use of Food and Drug ...

The new MHRA sandbox will allow innovators to test AI systems to enhance medicines’ safety and predict side effects.

The country’s new regulatory pathway promises to accelerate access to advanced therapies for Chinese patients, but may change ...

Industries from semiconductors to fiber-optic cables stand to benefit from space research and manufacturing, but experts told ...

FDA's draft guidance shows gene therapy developers how to use prior knowledge and platform data to accelerate regulatory ...